Cancer-Symptoms.org
|
|
Children's Cancer CentersSurvival rates for childhood cancer have risen sharply over the past 25 years. In the United States, more than 75 percent of children with cancer are now alive 5 years after diagnosis, compared with about 60 percent in the mid-1970s (1). Much of this dramatic improvement is due to the development of improved therapies at children’s cancer centers, where the majority of children with cancer have their treatment.
Children’s cancer centers are hospitals or units in hospitals that
specialize in the diagnosis and treatment of cancer in children and
adolescents. Most children’s, or
pediatric, cancer centers treat patients up to the age of 20. The following groups have established standards for children’s cancer centers or programs: These groups agree that a childhood cancer center should be staffed by a
team of trained pediatric
oncologists (doctors who specialize in childhood cancer) and other
specialists. Other members of the health professional team usually include
pediatric surgeons, specialist
surgeons (for instance
neurosurgeons and urologic surgeons),
radiation oncologists,
pathologists, nurses, consulting pediatric specialists, psychiatrists,
oncology social workers,
nutritionists, and home health care professionals—all with expertise in
treating children and adolescents with cancer. Together, these professionals
offer comprehensive care. Because childhood cancer is relatively rare, it is important to seek
treatment in centers that specialize in the treatment of children with
cancer. Specialized cancer programs at comprehensive,
multidisciplinary cancer centers follow established
protocols (step-by-step guidelines for treatment). These protocols are
carried out using a team approach. The team of health professionals is
involved in designing the appropriate treatment and support program for the
child and the child’s family. In addition, these centers participate in
specially designed and monitored research studies that help develop more
effective treatments and address issues of long-term childhood cancer
survival. Not necessarily. Participation in research studies is always voluntary.
Parents and patients may choose to receive treatment as part of a clinical
trial (research study); only patients and parents who wish to do so take
part. However, a large number of children who go to pediatric cancer centers
take part in clinical trials. About 70 percent of children with cancer are
treated in an National Cancer institute-sponsored clinical trial at some point during their
illness. In cancer research, a clinical trial is a study designed to show how a particular strategy—for instance, a promising anticancer drug, a new diagnostic test, or a possible way to prevent cancer—affects the people who receive it. Treatment clinical studies fall into three categories: One advantage is the possibility that a new treatment (or diagnostic test or preventive measure) will turn out to be better than a more established method. Patients who take part in approaches that prove to be better have the first chance to benefit from them. In phase III clinical trials, in which one treatment is compared with another, patients receive either the most advanced and accepted treatment for the kind of cancer they have—known as the “standard” treatment—or a new treatment that has shown promise of being at least as beneficial as the standard treatment. People who take part in clinical trials receive specialized care under a
very precise set of directions, or protocol. To ensure quality care, highly
trained and experienced cancer specialists design, review, and approve each
protocol. In addition, all participants in clinical trials are carefully
monitored during the study and are followed afterwards. Participants are
often included in a network of clinical trials carried out around the
country. In this network, doctors and researchers share their ideas and
experience, and patients receive the benefit of the shared knowledge. Clinical trials can involve risks as well as benefits. All cancer
treatments have
side effects, but treatments being studied may have side effects that
are not yet understood as well as the side effects of standard treatments.
The potential risks and benefits of each study are explained during the
informed consent process, when patients and families discuss all aspects
of the study with their doctors or nurses before deciding whether to
participate. Some health plans cover part or all of the cost of care at children’s
cancer centers, but benefits vary from plan to plan. Questions or concerns
about health care costs should be discussed with a medical social worker or
the hospital or clinic billing office. FinaNational Cancer instituteal assistance and resources to
cover health care costs may be available. Children with cancer can receive treatment in clinical trials at the
National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.
Two branches of the National Cancer institute that study specific types of cancer have their own
contact points: A child’s pediatrician or family doctor often can provide a referral to a
children’s cancer center. Families and health professionals also can call
the National Cancer institute’s Cancer Information Service (CIS) at 1–800–4–CANCER to learn about
children’s cancer centers that belong to the Children’s Oncology Group
(COG). All of the cancer centers that participate in these Groups have met
strict standards of excellence for childhood cancer care. A directory of
COG institutions by state is also available at
http://www.curesearch.org/resources/cog.aspx on the Internet. Many families receive helpful information from their doctors and nurses. Treatment centers often have social work departments that can provide assistance. In addition, various organizations offer support to families, including help with transportation, lodging, and finaNational Cancer instituteal assistance. Sources of help include the following organizations:
|
|
|